Octanoic acid (OA) reduced both central and peripheral components of postural tremor. The central and peripheral tremor components were positively correlated, both after placebo and OA. It is likely that the mechanical tremor component is driven by the magnitude of the central tremor.
h i g h l i g h t s
Octanoic acid (OA) reduced both central and peripheral components of postural tremor. The central and peripheral tremor components were positively correlated, both after placebo and OA. It is likely that the mechanical tremor component is driven by the magnitude of the central tremor.
a b s t r a c t
Objective: To investigate the effect of octanoic acid (OA) on the peripheral component of tremor, as well as OA's differential effects on the central and peripheral tremor component in essential tremor (ET) patients. Methods: We analyzed postural tremor accelerometry data from a double-blind placebo-controlled crossover study evaluating the effect of 4 mg/kg OA in ET. The weighted condition was used to identify tremor power for both the central and peripheral tremor components. Exploratory non-parametric statistical analyses were used to describe the relation between the central and peripheral component of tremor power. Results: A peripheral tremor component was identified in 4 out of 18 subjects. Tremor power was reduced after OA administration in both the central and the peripheral tremor component. There was a positive correlation of tremor power between the central and peripheral component, both after placebo and OA. Conclusions: When present, the peripheral component was closely related to the central tremor component. We hypothesize that the magnitude of the peripheral mechanical component of tremor is determined by that of the central component. 
Introduction
Essential tremor (ET) is one of the most common neurological movement disorders with a prevalence of 3.06% among individuals aged 50 or older (Wenning et al., 2005) . In general, tremor in ET is progressive, eventually producing disabilities with basic daily activities such as eating, writing, body care, and driving. However, there is currently no curative therapy, and medical agents such as propranolol and primidone are only symptomatic therapeutic options. Only about half of ET patients respond to these two first-line drugs, and this response is modest. Elderly patients are particularly susceptible to side effects of these drugs, and fewer than 20% of ET patients can tolerate the side effects (Deuschl et al., 2011) .
Up to 74% of subjects with ET report a significant reduction in tremor intensity after ingesting small amounts of ethanol (Koller et al., 1994) . However, ethanol is not a reasonable therapeutic option due to its narrow therapeutic window and risk of excessive alcohol use. The long chain alcohol 1-octanol has been explored for potentially achieving similar beneficial effects in alcohol- 
